About the project and the involvement opportunity
Each year RSV causes an estimated 3.2 million hospital admissions and 118,200 deaths in children under five years of age, predominantly in low and middle-income countries. While this burden is greatest in the young, RSV is clinically significant for all age groups, as re-infection can occur throughout life.
About the position
Virex is wanting to convene a Consumer Advisory Group to assist with guide and shape the development of our antiviral drug, GlyXine using your lived experience.
What am I expected to do?
Review documents, group discussions on understanding your symptoms, challenges of living with RSV infections and helping the researchers understand the consumer perspective on how to administer the drugs to combat the infections.
What skills or experience do I need?
We seek consumers with a lived experience in the following areas:
- Parent of a child with RSV or have been vaccinated for RSV
- You are 65 years or older and have had RSV
- Have had the vaccination for RSV
- Carer for any of the above
How long am I expected to be involved?
The project will run until April 2024.
Where will meetings be held?
Meetings will be held online Bimonthly unless otherwise decided by the group.
What support is offered?
$37.50 per hour honorarium. Training and support is offered by the Consumer and Community Involvement Program.
Note: By checking this box, you agree to allow us to save your details to a cookie on your device. Your information will not be saved to our servers and will only be used to assist in pre-populating your details on other registration forms. You can clear your saved details by removing this cookie through your browser settings.